Avijeet K. Mishra

Hematology | Oncology
3333 Burnet Ave
Cincinnati, OH 45229

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.

A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.

Journal: Science translational medicine
Published: August 19, 2026

Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia.

Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia.

Journal: The New England journal of medicine
Published: December 09, 2025

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Journal: Leukemia
Published: October 06, 2025

Long-term outcomes of genome-edited "universal" CAR19 T cells for relapsed/refractory B-ALL at a single pediatric center.

Long-term outcomes of genome-edited "universal" CAR19 T cells for relapsed/refractory B-ALL at a single pediatric center.

Journal: Blood advances
Published: March 03, 2025

Practice guideline: Preparation for CAR T-cell therapy in children and young adults with B-acute lymphoblastic leukaemia.

Practice guideline: Preparation for CAR T-cell therapy in children and young adults with B-acute lymphoblastic leukaemia.

Journal: British journal of haematology
Published: December 05, 2023

Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.

Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 15, 2023

Azacitidine and venetoclax for post-transplant relapse in a case of CBFA2T3/GLIS2 childhood acute myeloid leukaemia.

Azacitidine and venetoclax for post-transplant relapse in a case of CBFA2T3/GLIS2 childhood acute myeloid leukaemia.

Journal: Pediatric blood & cancer
Published: May 08, 2021
Showing 1-7 of 7

Last Updated: 09/26/2026